2023-2029 Global Molecular Diagnostics Point of Care Industry Research & Trends Analysis Report
2023-2029 Global Molecular Diagnostics Point of Care Industry Research & Trends Analysis Report
Analysis of the Molecular Diagnostics Point of Care Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for Molecular Diagnostics Point of Care should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Assays and Kits segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Tumor has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Molecular Diagnostics Point of Care include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, Binx Health, BioMerieux, Co-Diagnostics and DanaherCorporation, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report aims to provide a comprehensive study of the global market for Molecular Diagnostics Point of Care.
Key Highlights of the Report
(1) Global Molecular Diagnostics Point of Care market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Molecular Diagnostics Point of Care market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Molecular Diagnostics Point of Care market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Molecular Diagnostics Point of Care segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Molecular Diagnostics Point of Care segment by type and by application and regional segment by type and by application.
(6) Molecular Diagnostics Point of Care industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Assays and Kits
Instruments and Analyzers
Software and Services
Others
Market segment by application, can be divided into
Tumor
Hematology
Endocrinology
Infectious Disease
Others
Market segment by players, this report covers
Abbott Laboratories
Abaxis
Bayer Healthcare
Bio-Rad Laboratories
Becton Dickinson and Company
Binx Health
BioMerieux
Co-Diagnostics
DanaherCorporation
Dako
F. Hoffmann
OraSure Technologies
Roche Diagnostics
Nipro Diagnostics
Genestat
Meridian Bioscience
Molbio Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Visby Medical
Wuhan Easy Diagnosis Biomedicine
Beijing Tiandz
Beijing Content
1 Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics Point of Care
1.2 Global Molecular Diagnostics Point of Care Market Size and Forecast
1.3 China Molecular Diagnostics Point of Care Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Molecular Diagnostics Point of Care Share in Global Market, 2018-2029
1.4.2 Molecular Diagnostics Point of Care Market Size: China VS Global, 2018-2029
1.5 Molecular Diagnostics Point of Care Market Dynamics
1.5.1 Molecular Diagnostics Point of Care Market Drivers
1.5.2 Molecular Diagnostics Point of Care Market Restraints
1.5.3 Molecular Diagnostics Point of Care Industry Trends
1.5.4 Molecular Diagnostics Point of Care Industry Policy
2 Global Competitive Situation by Company
2.1 Global Molecular Diagnostics Point of Care Revenue by Company (2018-2023)
2.2 Global Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Molecular Diagnostics Point of Care Concentration Ratio
2.4 Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans
2.5 Global Molecular Diagnostics Point of Care Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Molecular Diagnostics Point of Care Revenue by Company (2018-2023)
3.2 China Molecular Diagnostics Point of Care Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Molecular Diagnostics Point of Care, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Molecular Diagnostics Point of Care Industry Chain
4.2 Molecular Diagnostics Point of Care Upstream Analysis
4.3 Molecular Diagnostics Point of Care Midstream Analysis
4.4 Molecular Diagnostics Point of Care Downstream Analysis
5 Sights by Type
5.1 Molecular Diagnostics Point of Care Classification
5.1.1 Assays and Kits
5.1.2 Instruments and Analyzers
5.1.3 Software and Services
5.1.4 Others
5.2 By Type, Global Molecular Diagnostics Point of Care Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Molecular Diagnostics Point of Care Revenue, 2018-2029
6 Sights by Application
6.1 Molecular Diagnostics Point of Care Segment by Application
6.1.1 Tumor
6.1.2 Hematology
6.1.3 Endocrinology
6.1.4 Infectious Disease
6.1.5 Others
6.2 By Application, Global Molecular Diagnostics Point of Care Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Molecular Diagnostics Point of Care Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Molecular Diagnostics Point of Care Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Molecular Diagnostics Point of Care Market Size, 2018-2029
7.3 North America
7.3.1 North America Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Molecular Diagnostics Point of Care Market Size Market Share
7.4 Europe
7.4.1 Europe Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Molecular Diagnostics Point of Care Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Market Size Market Share
7.6 South America
7.6.1 South America Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Molecular Diagnostics Point of Care Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Molecular Diagnostics Point of Care Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Molecular Diagnostics Point of Care Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Molecular Diagnostics Point of Care Market Size, 2018-2029
8.3.2 By Company, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Molecular Diagnostics Point of Care Market Size, 2018-2029
8.4.2 By Company, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Molecular Diagnostics Point of Care Market Size, 2018-2029
8.5.2 By Company, China Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.5.3 By Type, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Molecular Diagnostics Point of Care Market Size, 2018-2029
8.6.2 By Company, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Molecular Diagnostics Point of Care Market Size, 2018-2029
8.7.2 By Company, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Molecular Diagnostics Point of Care Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Molecular Diagnostics Point of Care Market Size, 2018-2029
8.9.2 By Company, India Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.9.3 By Type, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Molecular Diagnostics Point of Care Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Laboratories Company Profile and Main Business
9.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application
9.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.1.5 Abbott Laboratories Recent Developments
9.2 Abaxis
9.2.1 Abaxis Company Information, Head Office, Market Area and Industry Position
9.2.2 Abaxis Company Profile and Main Business
9.2.3 Abaxis Molecular Diagnostics Point of Care Models, Specifications and Application
9.2.4 Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.2.5 Abaxis Recent Developments
9.3 Bayer Healthcare
9.3.1 Bayer Healthcare Company Information, Head Office, Market Area and Industry Position
9.3.2 Bayer Healthcare Company Profile and Main Business
9.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application
9.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.3.5 Bayer Healthcare Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
9.4.2 Bio-Rad Laboratories Company Profile and Main Business
9.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application
9.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Becton Dickinson and Company
9.5.1 Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position
9.5.2 Becton Dickinson and Company Company Profile and Main Business
9.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications and Application
9.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.5.5 Becton Dickinson and Company Recent Developments
9.6 Binx Health
9.6.1 Binx Health Company Information, Head Office, Market Area and Industry Position
9.6.2 Binx Health Company Profile and Main Business
9.6.3 Binx Health Molecular Diagnostics Point of Care Models, Specifications and Application
9.6.4 Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.6.5 Binx Health Recent Developments
9.7 BioMerieux
9.7.1 BioMerieux Company Information, Head Office, Market Area and Industry Position
9.7.2 BioMerieux Company Profile and Main Business
9.7.3 BioMerieux Molecular Diagnostics Point of Care Models, Specifications and Application
9.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.7.5 BioMerieux Recent Developments
9.8 Co-Diagnostics
9.8.1 Co-Diagnostics Company Information, Head Office, Market Area and Industry Position
9.8.2 Co-Diagnostics Company Profile and Main Business
9.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
9.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.8.5 Co-Diagnostics Recent Developments
9.9 DanaherCorporation
9.9.1 DanaherCorporation Company Information, Head Office, Market Area and Industry Position
9.9.2 DanaherCorporation Company Profile and Main Business
9.9.3 DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications and Application
9.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.9.5 DanaherCorporation Recent Developments
9.10 Dako
9.10.1 Dako Company Information, Head Office, Market Area and Industry Position
9.10.2 Dako Company Profile and Main Business
9.10.3 Dako Molecular Diagnostics Point of Care Models, Specifications and Application
9.10.4 Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.10.5 Dako Recent Developments
9.11 F. Hoffmann
9.11.1 F. Hoffmann Company Information, Head Office, Market Area and Industry Position
9.11.2 F. Hoffmann Company Profile and Main Business
9.11.3 F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications and Application
9.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.11.5 F. Hoffmann Recent Developments
9.12 OraSure Technologies
9.12.1 OraSure Technologies Company Information, Head Office, Market Area and Industry Position
9.12.2 OraSure Technologies Company Profile and Main Business
9.12.3 OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications and Application
9.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.12.5 OraSure Technologies Recent Developments
9.13 Roche Diagnostics
9.13.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position
9.13.2 Roche Diagnostics Company Profile and Main Business
9.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
9.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.13.5 Roche Diagnostics Recent Developments
9.14 Nipro Diagnostics
9.14.1 Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position
9.14.2 Nipro Diagnostics Company Profile and Main Business
9.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
9.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.14.5 Nipro Diagnostics Recent Developments
9.15 Genestat
9.15.1 Genestat Company Information, Head Office, Market Area and Industry Position
9.15.2 Genestat Company Profile and Main Business
9.15.3 Genestat Molecular Diagnostics Point of Care Models, Specifications and Application
9.15.4 Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.15.5 Genestat Recent Developments
9.16 Meridian Bioscience
9.16.1 Meridian Bioscience Company Information, Head Office, Market Area and Industry Position
9.16.2 Meridian Bioscience Company Profile and Main Business
9.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications and Application
9.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.16.5 Meridian Bioscience Recent Developments
9.17 Molbio Diagnostics
9.17.1 Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position
9.17.2 Molbio Diagnostics Company Profile and Main Business
9.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
9.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.17.5 Molbio Diagnostics Recent Developments
9.18 Siemens Healthcare
9.18.1 Siemens Healthcare Company Information, Head Office, Market Area and Industry Position
9.18.2 Siemens Healthcare Company Profile and Main Business
9.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application
9.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.18.5 Siemens Healthcare Recent Developments
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.19.2 Thermo Fisher Scientific Company Profile and Main Business
9.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications and Application
9.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.19.5 Thermo Fisher Scientific Recent Developments
9.20 Visby Medical
9.20.1 Visby Medical Company Information, Head Office, Market Area and Industry Position
9.20.2 Visby Medical Company Profile and Main Business
9.20.3 Visby Medical Molecular Diagnostics Point of Care Models, Specifications and Application
9.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.20.5 Visby Medical Recent Developments
9.21 Wuhan Easy Diagnosis Biomedicine
9.21.1 Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, Market Area and Industry Position
9.21.2 Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business
9.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications and Application
9.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
9.22 Beijing Tiandz
9.22.1 Beijing Tiandz Company Information, Head Office, Market Area and Industry Position
9.22.2 Beijing Tiandz Company Profile and Main Business
9.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications and Application
9.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.22.5 Beijing Tiandz Recent Developments
9.23 Beijing Content
9.23.1 Beijing Content Company Information, Head Office, Market Area and Industry Position
9.23.2 Beijing Content Company Profile and Main Business
9.23.3 Beijing Content Molecular Diagnostics Point of Care Models, Specifications and Application
9.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
9.23.5 Beijing Content Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Molecular Diagnostics Point of Care Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Molecular Diagnostics Point of Care Market Restraints
Table 3. Molecular Diagnostics Point of Care Market Trends
Table 4. Molecular Diagnostics Point of Care Industry Policy
Table 5. Global Molecular Diagnostics Point of Care Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Molecular Diagnostics Point of Care Revenue Market Share by Company (2018-2023)
Table 7. Global Molecular Diagnostics Point of Care Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans
Table 9. Global Molecular Diagnostics Point of Care Manufacturers Product Type
Table 10. China Molecular Diagnostics Point of Care Revenue by Company (2018-2023) & (US$ million)
Table 11. China Molecular Diagnostics Point of Care Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Molecular Diagnostics Point of Care Upstream (Raw Materials)
Table 13. Global Molecular Diagnostics Point of Care Typical Customers
Table 14. Molecular Diagnostics Point of Care Typical Distributors
Table 15. By Type, Global Molecular Diagnostics Point of Care Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Molecular Diagnostics Point of Care Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Molecular Diagnostics Point of Care Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Molecular Diagnostics Point of Care Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029
Table 22. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
Table 23. Abbott Laboratories Company Profile and Main Business
Table 24. Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application
Table 25. Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 26. Abbott Laboratories Recent Developments
Table 27. Abaxis Company Information, Head Office, Market Area and Industry Position
Table 28. Abaxis Company Profile and Main Business
Table 29. Abaxis Molecular Diagnostics Point of Care Models, Specifications and Application
Table 30. Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 31. Abaxis Recent Developments
Table 32. Bayer Healthcare Company Information, Head Office, Market Area and Industry Position
Table 33. Bayer Healthcare Company Profile and Main Business
Table 34. Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application
Table 35. Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 36. Bayer Healthcare Recent Developments
Table 37. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position
Table 38. Bio-Rad Laboratories Company Profile and Main Business
Table 39. Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application
Table 40. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 41. Bio-Rad Laboratories Recent Developments
Table 42. Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position
Table 43. Becton Dickinson and Company Company Profile and Main Business
Table 44. Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications and Application
Table 45. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 46. Becton Dickinson and Company Recent Developments
Table 47. Binx Health Company Information, Head Office, Market Area and Industry Position
Table 48. Binx Health Company Profile and Main Business
Table 49. Binx Health Molecular Diagnostics Point of Care Models, Specifications and Application
Table 50. Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 51. Binx Health Recent Developments
Table 52. BioMerieux Company Information, Head Office, Market Area and Industry Position
Table 53. BioMerieux Company Profile and Main Business
Table 54. BioMerieux Molecular Diagnostics Point of Care Models, Specifications and Application
Table 55. BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 56. BioMerieux Recent Developments
Table 57. Co-Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 58. Co-Diagnostics Company Profile and Main Business
Table 59. Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
Table 60. Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 61. Co-Diagnostics Recent Developments
Table 62. DanaherCorporation Company Information, Head Office, Market Area and Industry Position
Table 63. DanaherCorporation Company Profile and Main Business
Table 64. DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications and Application
Table 65. DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 66. DanaherCorporation Recent Developments
Table 67. Dako Company Information, Head Office, Market Area and Industry Position
Table 68. Dako Company Profile and Main Business
Table 69. Dako Molecular Diagnostics Point of Care Models, Specifications and Application
Table 70. Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 71. Dako Recent Developments
Table 72. F. Hoffmann Company Information, Head Office, Market Area and Industry Position
Table 73. F. Hoffmann Company Profile and Main Business
Table 74. F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications and Application
Table 75. F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 76. F. Hoffmann Recent Developments
Table 77. OraSure Technologies Company Information, Head Office, Market Area and Industry Position
Table 78. OraSure Technologies Company Profile and Main Business
Table 79. OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications and Application
Table 80. OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 81. OraSure Technologies Recent Developments
Table 82. Roche Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 83. Roche Diagnostics Company Profile and Main Business
Table 84. Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
Table 85. Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 86. Roche Diagnostics Recent Developments
Table 87. Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 88. Nipro Diagnostics Company Profile and Main Business
Table 89. Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
Table 90. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 91. Nipro Diagnostics Recent Developments
Table 92. Genestat Company Information, Head Office, Market Area and Industry Position
Table 93. Genestat Company Profile and Main Business
Table 94. Genestat Molecular Diagnostics Point of Care Models, Specifications and Application
Table 95. Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 96. Genestat Recent Developments
Table 97. Meridian Bioscience Company Information, Head Office, Market Area and Industry Position
Table 98. Meridian Bioscience Company Profile and Main Business
Table 99. Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications and Application
Table 100. Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 101. Meridian Bioscience Recent Developments
Table 102. Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 103. Molbio Diagnostics Company Profile and Main Business
Table 104. Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application
Table 105. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 106. Molbio Diagnostics Recent Developments
Table 107. Siemens Healthcare Company Information, Head Office, Market Area and Industry Position
Table 108. Siemens Healthcare Company Profile and Main Business
Table 109. Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application
Table 110. Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 111. Siemens Healthcare Recent Developments
Table 112. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 113. Thermo Fisher Scientific Company Profile and Main Business
Table 114. Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications and Application
Table 115. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 116. Thermo Fisher Scientific Recent Developments
Table 117. Visby Medical Company Information, Head Office, Market Area and Industry Position
Table 118. Visby Medical Company Profile and Main Business
Table 119. Visby Medical Molecular Diagnostics Point of Care Models, Specifications and Application
Table 120. Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 121. Visby Medical Recent Developments
Table 122. Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, Market Area and Industry Position
Table 123. Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business
Table 124. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications and Application
Table 125. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 126. Wuhan Easy Diagnosis Biomedicine Recent Developments
Table 127. Beijing Tiandz Company Information, Head Office, Market Area and Industry Position
Table 128. Beijing Tiandz Company Profile and Main Business
Table 129. Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications and Application
Table 130. Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 131. Beijing Tiandz Recent Developments
Table 132. Beijing Content Company Information, Head Office, Market Area and Industry Position
Table 133. Beijing Content Company Profile and Main Business
Table 134. Beijing Content Molecular Diagnostics Point of Care Models, Specifications and Application
Table 135. Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023
Table 136. Beijing Content Recent Developments
List of Figure
Figure 1. Molecular Diagnostics Point of Care Picture
Figure 2. Global Molecular Diagnostics Point of Care Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Molecular Diagnostics Point of Care Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Molecular Diagnostics Point of Care Market Share of Global
Figure 5. Global Molecular Diagnostics Point of Care Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Molecular Diagnostics Point of Care Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Molecular Diagnostics Point of Care Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Molecular Diagnostics Point of Care Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Molecular Diagnostics Point of Care Industry Chain
Figure 10. Assays and Kits
Figure 11. Instruments and Analyzers
Figure 12. Software and Services
Figure 13. Others
Figure 14. By Type, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029
Figure 16. Tumor
Figure 17. Hematology
Figure 18. Endocrinology
Figure 19. Infectious Disease
Figure 20. Others
Figure 21. By Application, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million
Figure 22. By Application, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029
Figure 23. By Region, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029
Figure 24. North America Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, North America Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
Figure 26. Europe Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
Figure 28. Asia Pacific Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
Figure 30. South America Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, South America Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023
Figure 32. Middle East & Africa Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million
Figure 33. U.S. Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, U.S. Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 35. By Type, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 36. By Application, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 37. Europe Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, Europe Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 39. By Type, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 40. By Application, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 41. China Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, China Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 43. By Type, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 44. By Application, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 45. Japan Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, Japan Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 47. By Type, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 48. By Application, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 49. South Korea Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, South Korea Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 51. By Type, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 52. By Application, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 53. Southeast Asia Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, Southeast Asia Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 55. By Type, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 56. By Application, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 57. India Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, India Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 59. By Type, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 60. By Application, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 61. Middle East & Asia Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)
Figure 62. By Company, Middle East & Asia Molecular Diagnostics Point of Care Market Share, 2018-2023
Figure 63. By Type, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 64. By Application, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029
Figure 65. Research Methodology
Figure 66. Breakdown of Primary Interviews
Figure 67. Bottom-up Approaches
Figure 68. Top-down Approaches
Research Methodology:
Molecular Diagnostics Point of Care Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|